Potassium Clavulanate

Synopsis, Chemistry

APIs // Active Pharmaceutical Ingredients

41 Suppliers, 25 USDMF, 34 CEP/COS, 61 KDMF, 14 NDC API, 9 Listed Suppliers

PRICE INFORMATION

API Reference Price, API Exports, API Imports, FDF Exports, FDF Imports

DOSSIERs // Finished Dosage Forms

519 Dossiers, 73 FDA Orange Book, 221 Europe, 102 South Africa, 123 Listed Dossiers

DRUG PRODUCT COMPOSITION

TABLET;ORAL - 250MG;EQ 125MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET;ORAL - 500MG;EQ 125MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, FOR SUSPENSION;ORAL - 125MG/5ML;EQ 31.25MG BASE/5ML, FOR SUSPENSION;ORAL - 250MG/5ML;EQ 62.5MG BASE/5ML, TABLET;ORAL - 875MG;EQ 125MG BASE, FOR SUSPENSION;ORAL - 200MG/5ML;EQ 28.5MG BASE/5ML, FOR SUSPENSION;ORAL - 400MG/5ML;EQ 57MG BASE/5ML, FOR SUSPENSION;ORAL - 600MG/5ML;EQ 42.9MG BASE/5ML, TABLET, EXTENDED RELEASE;ORAL - 1GM;EQ 62.5MG BASE

RELATED EXCIPIENT COMPANIES

Suppliers, 31 BASF, 17 Kerry, 16 Roquette, 16 Microlex e.U, 14 DKSH, 13 SPI Pharma, 12 Seppic, 11 Corel Pharma Chem, 11 Sigachi Industries, 11 Gangwal Chemicals, 9 Gangwal Healthcare, 9 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 6 Actylis, 6 Lonza Capsugel, 6 Nanjing Well Pharmaceutical, 5 Kima Chemical, 5 Rochem International Inc, 5 Boai NKY Pharmaceuticals Ltd, 5 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 5 Ideal Cures Pvt Ltd, 4 Vasa Pharmachem, 4 Pharmatrans-Sanaq, 4 The Dow Chemical Company, 4 Prachin Chemical, 4 DFE Pharma, 3 Ingredion Pharma Solutions, 2 Jai Radhe Sales, 2 Nomisma Healthcare, 2 Clariant, 2 Seqens, 2 Finar, 2 Ulanqab Kema New Material, 1 Pfanstiehl, 1 Nanjing Bold Chemical, 1 ACG Worldwide, 1 Qualicaps, 1 Avesta Pharma, 1 Aeon Procare, 1 Pharm-RX Chemical, 1 Qianhao Chemical (Hebei) Co., Ltd, 1 Shijiazhuang Huaxu Pharmaceutical, 1 Alcedo Pharmachem, 1 Evonik, 1 Vertellus

EXCIPIENTS BY APPLICATIONS

61 Fillers, Diluents & Binders, 51 Coating Systems & Additives, 40 Disintegrants & Superdisintegrants, 33 Thickeners and Stabilizers, 33 Direct Compression, 32 Controlled & Modified Release, 30 Solubilizers, 26 Granulation, 21 Topical, 20 Film Formers & Plasticizers, 20 Taste Masking, 17 Parenteral, 17 Lubricants & Glidants, 15 Chewable & Orodispersible Aids, 11 Co-Processed Excipients, 10 Rheology Modifiers, 8 Emulsifying Agents, 7 API Stability Enhancers, 5 Empty Capsules, 5 Surfactant & Foaming Agents, 4 Vegetarian Capsules, 4 Coloring Agents

GLOBAL SALES INFORMATION

193 Finished Drug Prices

193 Finished Drug Prices

MARKET PLACE

44 APIs, 9 DOSSIERS // FDF

REF. STANDARDS & IMPURITIES

4 EDQM, 4 Others

DIGITAL CONTENT

3 Data Compilation & Company Tracker #PharmaFlow, 11 News

Latest U.S. Prescription Data for Drugs containing Potassium Clavulanate under Medicare's Part D Prescription Drug Program. Original Data: Centers for Medicare & Medicaid Services Website

Potassium Clavulanate

Synopsis

Chemistry

APIs // Active Pharmaceutical Ingredients

41 Suppliers

25 USDMF

34 CEP/COS

61 KDMF

14 NDC API

9 Listed Suppliers

PRICE INFORMATION

API Reference Price

API Exports

API Imports

FDF Exports

FDF Imports

DOSSIERs // Finished Dosage Forms

519 Dossiers

73 FDA Orange Book

221 Europe

102 South Africa

123 Listed Dossiers

DRUG PRODUCT COMPOSITION

TABLET;ORAL - 250MG;EQ 125MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

TABLET;ORAL - 500MG;EQ 125MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

FOR SUSPENSION;ORAL - 125MG/5ML;EQ 31.25MG BASE/5ML

FOR SUSPENSION;ORAL - 250MG/5ML;EQ 62.5MG BASE/5ML

TABLET;ORAL - 875MG;EQ 125MG BASE

FOR SUSPENSION;ORAL - 200MG/5ML;EQ 28.5MG BASE/5ML

FOR SUSPENSION;ORAL - 400MG/5ML;EQ 57MG BASE/5ML

FOR SUSPENSION;ORAL - 600MG/5ML;EQ 42.9MG BASE/5ML

TABLET, EXTENDED RELEASE;ORAL - 1GM;EQ 62.5MG BASE

RELATED EXCIPIENT COMPANIES

Suppliers

31 BASF

17 Kerry

16 Roquette

16 Microlex e.U

14 DKSH

13 SPI Pharma

12 Seppic

11 Corel Pharma Chem

11 Sigachi Industries

11 Gangwal Chemicals

9 Gangwal Healthcare

9 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd

6 Actylis

6 Lonza Capsugel

6 Nanjing Well Pharmaceutical

5 Kima Chemical

5 Rochem International Inc

5 Boai NKY Pharmaceuticals Ltd

5 Shanghai Shenmei Pharmaceutical Technology Co., Ltd

5 Ideal Cures Pvt Ltd

4 Vasa Pharmachem

4 Pharmatrans-Sanaq

4 The Dow Chemical Company

4 Prachin Chemical

4 DFE Pharma

3 Ingredion Pharma Solutions

2 Jai Radhe Sales

2 Nomisma Healthcare

2 Clariant

2 Seqens

2 Finar

2 Ulanqab Kema New Material

1 Pfanstiehl

1 Nanjing Bold Chemical

1 ACG Worldwide

1 Qualicaps

1 Avesta Pharma

1 Aeon Procare

1 Pharm-RX Chemical

1 Qianhao Chemical (Hebei) Co., Ltd

1 Shijiazhuang Huaxu Pharmaceutical

1 Alcedo Pharmachem

1 Evonik

1 Vertellus

EXCIPIENTS BY APPLICATIONS

TABLET;ORAL - 250MG;EQ 125MG BASE Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

TABLET;ORAL - 500MG;EQ 125MG BASE Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons